Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 44
1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can blood lactate levels help guide treatment for birds suffering from monofilament line entanglement injuries?

Fishing line entanglement injuries are a common problem affecting over 200 different wildlife species globally...

Do fungi exposed to toxic waste produce novel antimicrobial agents?

We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

Community-based Leishmaniasis research in Sri Lanka

Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

Backer Badge Funded